Zobrazeno 1 - 10
of 27
pro vyhledávání: '"A. Oaknin"'
Autor:
Koppikar, S., Oaknin, A., Babu, K. Govind, Lorusso, D., Gupta, S., Wu, L.-Y., Rajabto, W., Harano, K., Hong, S.-H., Malik, R.A., Strebel, H., Aggarwal, I.M., Lai, C.-H., Dejthevaporn, T., Tangjitgamol, S., Cheng, W.F., Chay, W.Y., Benavides, D., Hashim, N.M., Moon, Y.W., Yunokawa, M., Anggraeni, T.D., Wei, W., Curigliano, G., Maheshwari, A., Mahantshetty, U., Sheshadri, S., Peters, S., Yoshino, T., Pentheroudakis, G.
Publikováno v:
In ESMO Open February 2023 8(1)
Autor:
Perez-Fidalgo, J.A., Cortés, A., Guerra, E., García, Y., Iglesias, M., Bohn Sarmiento, U., Calvo García, E., Manso Sánchez, L., Santaballa, A., Oaknin, A., Redondo, A., Rubio, M.J., González-Martín, A.
Publikováno v:
In ESMO Open August 2021 6(4)
Autor:
Banerjee, Susana, Gonzalez-Martin, Antonio, Harter, Philipp, Lorusso, Domenica, Moore, Kathleen N., Oaknin, Ana, Ray-Coquard, Isabelle
Publikováno v:
In ESMO Open 2020 5(6)
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
Autor:
Rodriguez-Freixinos, Victor, Ruiz-Pace, Fiorella, Fariñas-Madrid, Lorena, Garrido-Castro, Ana Christina, Villacampa, Guillermo, Nuciforo, Paolo, Vivancos, Ana, Dienstmann, Rodrigo, Oaknin, Ana
Publikováno v:
In ESMO Open 2019 4(2)
Autor:
Philipp Harter, Ana Oaknin, Isabelle Ray-Coquard, Domenica Lorusso, Kathleen N Moore, Antonio Gonzalez-Martin, Susana Banerjee
Publikováno v:
ESMO Open, Vol 5, Iss 6 (2020)
Poly(ADP-ribose) polymerase (PARP) inhibitor maintenance therapy is the latest breakthrough in the management of newly diagnosed advanced ovarian cancer. The results of the SOLO-1 trial in 2018 led to European Medicines Agency and Food and Drug Admin
Externí odkaz:
https://doaj.org/article/244e856198f544068a835c710b8f23b9
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Externí odkaz:
https://doaj.org/article/90052ef9d0e4444fa96da39829f90bc8
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
Autor:
Victor Rodriguez-Freixinos, Fiorella Ruiz-Pace, Lorena Fariñas-Madrid, Ana Christina Garrido-Castro, Guillermo Villacampa, Paolo Nuciforo, Ana Vivancos, Rodrigo Dienstmann, Ana Oaknin
Publikováno v:
ESMO Open, Vol 4, Iss 2 (2019)
Objectives Aberrant PI3K/AKT/mTOR activation is common in gynaecological malignancies. However, predictive biomarkers of response to PI3K pathway inhibitors (PAMi) have yet to be identified.Methods We analysed the outcomes of patients with advanced g
Externí odkaz:
https://doaj.org/article/cd76a2bf7a594e9cbafdf669d57b56f7
Autor:
García-Illescas, D., Grau Béjar, J.F., Navarro, V., Fariñas Madrid, L., Valdivia, A.A., Villacampa Javierre, G., Garcia Duran, C., Oaknin, A.
Publikováno v:
In ESMO Open February 2023 8(1) Supplement 1
Autor:
D. García-Illescas, J.F. Grau Béjar, V. Navarro, L. Fariñas Madrid, A.A. Valdivia, G. Villacampa Javierre, C. Garcia Duran, A. Oaknin
Publikováno v:
ESMO Open. 8:100827
Autor:
Andrés Redondo, M. Iglesias, E.M. Guerra, Ana Santaballa, L. Manso Sánchez, E. Calvo García, Ángel Fernández Cortés, Jose Alejandro Perez-Fidalgo, Y. García, Ana Oaknin, Antonio González-Martín, Mauricio Rubio, U. Bohn Sarmiento
Publikováno v:
ESMO Open
Esmo Open
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Scientia
Esmo Open
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Scientia
Background There is limited evidence for the benefit of olaparib in platinum-resistant ovarian cancer (PROC) patients with BRCA wild-type tumors. This study investigated whether this combination of a DNA-damaging chemotherapy plus olaparib is effecti